Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules
How Merck Plans to Set a Buffer for Keytruda's Patent Cliff
FDA Lifts Partial Hold on Merck, Daiichi's Phase 3 Lung Cancer Study
Breast Cancer Treatments Heat Up: Six Therapies Poised to Transform Patient Outcomes
Healthtech, Biotech: Why the UK Is Emerging as an Essential Hub
Servier Signs €1bn-Plus AI Pact with Iktos
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
Permittivity Provides an In-Line Cell Health Early-Warning System
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
TotalEnergies Inks 1GW Google Solar Deal
The Top 10 PharmTech Videos of 2025
Why Owning the Learning Loop Matters More Than Owning the Lab
Proteasomes: A Novel Approach to Target the Immune System
Report Says MSD Is in Talks to Buy Revolution Meds
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+
An Analysis of International Space Station Experiments
Lilly Strikes Again, Buying CAR-T Firm Orna for $2.4bn
Synthesia Hits $4B Valuation, Lets Employees Cash Out
Solve Therapeutics Secures $120 Million
Advancing Pharmaceutical Quality Through Integrated Digital Systems and Collaborative Scientific Innovation
Haisco Steps Onto Global Stage with Blue Chip NewCo Deal
Jim Cramer's Top 10 Things to Watch in the Stock Market Friday
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
FMC Raises €100M in Funding
Boehringer Signs €1bn+ Deal for Simcere IBD Candidate
2025 Novel Large Molecule FDA Drug Approvals
Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC
UK Tech Funding Drops 11% in 2025, but Late-Stage Capital Remains Resilient
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
Biotech Investors Bet on a 2026 Rebound as Deal Activity Accelerates
Merck Foundation Grant Advances Cardiovascular Care for Formerly Incarcerated Black Men
Sanofi Suffers Another Sales Dip For 'Gift to Public Health' Vaccines
INBRAIN’s “Rice‑sized” Graphene BCI Chip Marks New Phase in Merck Collaboration
White House’s Online Service for Drug Sales Debuts with Limited Impact on Prices
Eikon, a High-Profile Startup Led by Merck Vets, Seeks an IPO
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline
Biopharmas Axed 47% More Employees Year Over Year
Summit’s Potential Keytruda Rival Gets November FDA Decision Date
JPM: Illumina Launches 'Unprecedented' Disease Biology Atlas
At JPM26, Experts Try To Look Past the Most Favored Nation ‘Distraction’
Merck to Complete Acquisition of Cidara Therapeutics
U.S. Vaccine Approvals to Undergo Overhaul: What Do the Changes Mean?
Sun Pharma Says Talk of $10bn Organon Bid Is 'Speculative'
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence
Moderna, Merck Show Long-Term Survival For mRNA-Keytruda Combo